Post Categories
QPS Aids Development of Cannabinoid Chewing Gum, for MS Patients
August 11, 2015
Cannabinoid bioscience has come a long way. New York-based Axim Biotech is at the forefront, developing – among many other, related products – a…
Mental Vacation
August 11, 2015
Need a vacation? Don’t have time? Spend the next 45 seconds pretending you’re here….
Fast Track Routes for Medicines that address Unmet Medical Needs
July 27, 2015
Launch of two-month public consultations on revised guidelines on accelerated assessment and conditional marketing authorization The European Medicines Agency (EMA) has revised its guidelines…
Sports Nutrition Leadership, Benchtop to Countertop: Watch the Webinar on Building Better Beverages with panelist Doug Kalman, Director of Nutrition & Endocrinology at QPS MRA
July 29, 2015
Finding something tasty to drink at the mini-mart has gotten really complicated lately. Knowing the usual soft drinks are unhealthy, you may be tempted…
DMPK scientists from Exelixis and QPS publish on “Metabolism and Disposition of Cabozantinib in Healthy Male Volunteers and Pharmacologic Characterization of Its Major Metabolites” in DMD
July 27, 2015
Read the original Exelexis-supported publication in Drug Metabolism & Disposition (DMD). Cabozantinib (COMETRIQ®) inhibits the activity of tyrosine kinases including MET, VEGFRs and RET….
Dr. Diane Krieger from QPS MRA acknowledged in NEJM for her role as investigator in the SCALE Obesity and Prediabetes Study Group
July 27, 2015
The sheer abundance of diet drugs available suggests two things: 1) there is a huge market for them and 2) none of them work…
Hop on the QPS Bioanalysis Bus: Protein Quantitation by LC-MS/MS is Just Around the Corner
July 24, 2015
We love it when you notice! At the recent Sciex Users gathering of MS geeks in the 63th ASMS Annual Conference, one member of…
Regulatory Expertise Now Part of QPS Clinical Development Offerings
July 9, 2015
In July 2015, regulatory expert Patricia Baede joined QPS’ clinical development teams. With 20 years of experience in clinical trial conduct and all regulatory…
New Obesity Drug Shows Great Promise in Phase III Trials
June 22, 2022
Danish pharmaceutical giant Novo Nordisk changed the game last year, presenting data that suggested one of the company’s diabetes drugs was also highly effective…
Could a New Gap-Free Human Genome Make Personal DNA Sequencing “Routine” Care?
June 20, 2022
In 2003, while recognizing the 50th anniversary of the discovery of the double helix, researchers announced that the human genome had been sequenced —…
The Potential of a Self-Amplifying mRNA Vaccine Is Heard Loud and Clear
June 13, 2022
Thanks in large part to the efficacy of the Pfizer-BioNTech and Moderna mRNA vaccines, mask mandates, social distancing, and other COVID-19-related precautions have eased…
Immune Response Pathway a Possible Target to Treat Alzheimer’s Disease
June 6, 2022
Alzheimer’s disease (AD) is the most common form of dementia, affecting more than 50 million people globally. Projections show that, without a medical intervention,…
Freeze-Dried Mouse Sperm: A Revolution for In Vitro Fertilization?
June 1, 2022
When you think of a scientific laboratory, you might picture high-tech equipment, high-powered centrifuges, and bubbling vats of mysterious chemicals. However, the inner workings…
Stem Cells May Be at the Root of Baldness – As Well As the Cure
May 23, 2022
Within every hair follicle are the stem cells programmed to grow hair. These cells inhabit and grow in a region of the follicle called…
Introduction Real-world evidence (RWE) is accelerating drug development by using routinely collected patient health data, known as real-world data (RWD), to deliver insights beyond…
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
Introduction As global obesity rates continue to rise, the search for effective treatments is more critical than ever. Obesity is associated with an increased…
NEWARK, Del.—(BUSINESS WIRE)—QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalytics and clinical trials, is celebrating its 30-year anniversary in…
NEWARK, Del.—(BUSINESS WIRE)—QPS India, a subsidiary of QPS Holdings, LLC (QPS), a GLP/GCP-compliant global full-service Contract Research Organization, has achieved another significant milestone by…
TAIPEI, Taiwan—(BUSINESS WIRE)—QPS, a leading global contract research organization (CRO) specializing in preclinical and clinical drug development services, is pleased to announce the expansion…
